Multiple Myeloma and Plasma Cell Neoplasm
Showing NaN - NaN of 24
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Multiple Myeloma and Plasma Cell Tumor Trial in United States (arsenic trioxide)
Terminated
- Multiple Myeloma and Plasma Cell Neoplasm
- arsenic trioxide
-
La Jolla, California
- +5 more
Oct 2, 2020
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Withdrawn
- Leukemia
- +4 more
- alemtuzumab
- +6 more
-
La Jolla, California
- +23 more
Nov 25, 2019
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in United States (cyclosporine ophthalmic emulsion, )
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- cyclosporine ophthalmic emulsion
- placebo
-
Palo Alto, California
- +4 more
Jan 24, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago, Iowa City, Winston-Salem (Compound 506U78)
Terminated
- Chronic Myeloproliferative Disorders
- +4 more
- Compound 506U78
-
Chicago, Illinois
- +2 more
Jul 1, 2016
Multiple Myeloma and Plasma Cell Tumor Trial in Puerto Rico, South Africa, United States (dexamethasone, pamidronate disodium,
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- dexamethasone
- +3 more
-
Scottsdale, Arizona
- +77 more
Apr 2, 2014
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (biological, drug, procedure)
Completed
- Leukemia
- +3 more
- anti-thymocyte globulin
- +3 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Mar 6, 2014
Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (biological, drug, procedure)
Unknown status
- Multiple Myeloma and Plasma Cell Neoplasm
- filgrastim
- +7 more
-
Chicago, Illinois
- +1 more
Jan 3, 2014
Multiple Myeloma and Plasma Cell Tumor Trial in United States (ascorbic acid, bortezomib, melphalan)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- ascorbic acid
- +2 more
-
Fresno, California
- +7 more
Nov 5, 2013
Multiple Myeloma and Plasma Cell Tumor Trial in Canada, United States (dexamethasone, doxorubicin HCl, valspodar)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- dexamethasone
- +3 more
-
La Jolla, California
- +39 more
Aug 28, 2013
Anemia, Leukemia, Lymphoma Trial in United States (epoetin alfa, quality-of-life assessment)
Completed
- Anemia
- +3 more
- epoetin alfa
- quality-of-life assessment
-
Berkeley, California
- +17 more
Jul 1, 2013
Multiple Myeloma and Plasma Cell Tumor Trial in United States (bevacizumab, thalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- bevacizumab
- thalidomide
-
Duarte, California
- +3 more
Jun 20, 2013
Chronic Myeloproliferative Disorders, Infection, Leukemia Trial in United States (amphotericin B deoxycholate, nystatin)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- amphotericin B deoxycholate
- nystatin
-
Phoenix, Arizona
- +58 more
Mar 25, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Feb 8, 2013
Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (drug, procedure,
Completed
- Chronic Myeloproliferative Disorders
- +2 more
- busulfan
- +3 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Jun 8, 2012
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (allogeneic Epstein-Barr virus-specific cytotoxic T
Completed
- Leukemia
- +2 more
- allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes
- autologous Epstein-Barr virus-specific cytotoxic T lymphocytes
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
May 31, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (biological, drug, procedure)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- filgrastim
- +2 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012
Breast Cancer, Leukemia, Lymphoma Trial in Chicago (filgrastim, recombinant flt3 ligand, recombinant human thrombopoietin)
Completed
- Breast Cancer
- +4 more
- filgrastim
- +4 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Chicago (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +8 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Chicago (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- filgrastim
- +5 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Chicago (tocladesine)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 17, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Chicago, Cleveland (O6-benzylguanine, carmustine)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
-
Chicago, Illinois
- +2 more
Jun 9, 2010